Cargando…

Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among common cancers. The genomic landscape of PDAC is defined by four mutational pathways: kirsten rat sarcoma virus (KRAS), cellular tumor antigen p53 (TP53), cyclin dependent kinase inhibitor 2A (CDKN2A), and SMAD family...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Jung Yong, Cho, Hee Jin, Kim, Seung Tae, Park, Young Suk, Shin, Sang Hyun, Han, In Woong, Lee, Jeeyun, Heo, Jin Seok, Park, Joon Oh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404641/ https://www.ncbi.nlm.nih.gov/pubmed/34471425 http://dx.doi.org/10.1177/17588359211038478

Ejemplares similares

Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer
por: LIM, SUNG HEE, et al.
Publicado: (2023)

Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment
por: Lee, Min-Sang, et al.
Publicado: (2020)

The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer
por: Shin, Hyunju, et al.
Publicado: (2022)

Validation of original and alternative fistula risk scores in postoperative pancreatic fistula
por: Ryu, Youngju, et al.
Publicado: (2019)

Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era
por: Kim, Seung Tae, et al.
Publicado: (2016)

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy
por: Kim, Hyo Song, et al.
Publicado: (2016)

Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
por: Kim, Seung Tae, et al.
Publicado: (2018)

Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors
por: Park, Charny, et al.
Publicado: (2015)

Risk prediction platform for pancreatic fistula after pancreatoduodenectomy using artificial intelligence
por: Han, In Woong, et al.
Publicado: (2020)

15-Year Experience of Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer—A Korean Nationwide Investigation
por: Yoon, So Jeong, et al.
Publicado: (2023)

Intraoperative Positive Pancreatic Parenchymal Resection Margin: Is It a True Indication of Completion Total Pancreatectomy after Partial Pancreatectomy for Pancreatic Ductal Adenocarcinoma?
por: Jung, Ji-Hye, et al.
Publicado: (2022)

Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response
por: Hong, Jung Yong, et al.
Publicado: (2023)

Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study
por: Yoon, So Jeong, et al.
Publicado: (2022)

Does Preoperative Acute Pancreatitis Inevitably Delay Pancreatoduodenectomy in Patients with Periampullary Tumors?
por: Yoon, So Jeong, et al.
Publicado: (2021)

Prophylactic octreotide for postoperative pancreatic fistula in patients with pancreatoduodenectomy: Risk-stratified analysis
por: Yoon, So Jeong, et al.
Publicado: (2022)

Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation
por: Lee, Taehyang, et al.
Publicado: (2018)

Effects of cancer stigma on quality of life of patients with hepatobiliary and pancreatic cancer
por: Kim, Naru, et al.
Publicado: (2023)

Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment
por: Song, Haa-Na, et al.
Publicado: (2016)

The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis
por: Kim, Seung Tae, et al.
Publicado: (2015)

Clinical outcomes of pancreaticoduodenectomy for pancreatic ductal adenocarcinoma depending on preservation or resection of pylorus
por: Kim, Yeon Jin, et al.
Publicado: (2020)

Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system
por: Cho, Jang Ho, et al.
Publicado: (2019)

Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody
por: Lee, Jiyun, et al.
Publicado: (2019)

Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers
por: Kim, Ji Eun, et al.
Publicado: (2023)

Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker
por: Ryu, Daeun, et al.
Publicado: (2016)

The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma
por: Yoon, Sang Eun, et al.
Publicado: (2019)

The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
por: Yoon, Sang Eun, et al.
Publicado: (2018)

The Impact of Primary Tumor Sidedness on the Effect of Regorafenib in Refractory Metastatic Colorectal Cancer
por: Yoon, Sang Eun, et al.
Publicado: (2019)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
por: Kim, Seung Tae, et al.
Publicado: (2015)

Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
por: Kim, Seung Tae, et al.
Publicado: (2016)

The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
por: Lee, Su Jin, et al.
Publicado: (2018)

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs
por: Kim, Hee Kyung, et al.
Publicado: (2017)

The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
por: Kim, Seung Tae, et al.
Publicado: (2017)

Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions
por: Lin, Wei, et al.
Publicado: (2020)

National survey of Korean hepatobiliary-pancreatic surgeons on attitudes about the enhanced recovery after surgery protocol
por: Shin, Sang Hyun, et al.
Publicado: (2020)

Preparation of a Cross-Linked Cartilage Acellular-Matrix Film and Its In Vivo Evaluation as an Antiadhesive Barrier
por: Park, Joon Yeong, et al.
Publicado: (2019)

The impact of microsatellite instability status and sidedness of the primary tumor on the effect of bevacizumab-containing chemotherapy in patients with metastatic colorectal cancer
por: Kim, Seung Tae, et al.
Publicado: (2018)

Molecular Subgroup Analysis of Clinical Outcomes in a Phase 3 Study of Gemcitabine and Oxaliplatin with or without Erlotinib in Advanced Biliary Tract Cancer
por: Kim, Seung Tae, et al.
Publicado: (2015)

Pancreatic Tumors: Emphasis on CT Findings and Pathologic Classification
por: Cho, Hee-Woo, et al.
Publicado: (2011)

Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms
por: Jeong, Sun Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l67h2gdn4gfp0fal0subvjcr6n